Related Experiment Video
Updated: Aug 1, 2026
09:49
Isolation and Cannulation of Cerebral Parenchymal Arterioles
Published on: May 23, 2016
[Arterial hypertension, stress, and beta-blockers]
1Medicina Interna II, Università degli Studi, Ospedale L Sacco, Milano.
Cardiologia (Rome, Italy)
|December 1, 1993
Summary
Essential arterial hypertension may initially involve increased sympathetic nervous system activity. Stress and behavioral factors contribute, with sympathetic drive quantified by low frequency (LF) power in heart rate variability.
Area of Science:
- Cardiovascular Physiology
- Autonomic Nervous System Research
- Hypertension Pathophysiology
Context:
- Essential arterial hypertension is often linked to heightened sympathetic activity.
- Behavioral and mental factors, broadly termed 'stress,' are implicated in hypertension development and persistence.
- Quantifying sympathetic activity offers a method to assess stress's role in hypertension.
Purpose:
- To explore the role of mental stress in essential hypertension.
- To utilize heart rate variability (HRV) spectral analysis for quantifying sympathetic drive.
- To investigate the effects of beta-adrenergic blockade on sympathetic activity and baroreflex gain in hypertensives.
Summary:
- Hypertensives at rest exhibit increased low frequency (LF) power (sympathetic marker) relative to high frequency (HF) power (vagal marker) in HRV.
- Responsiveness to physical and mental stimuli is reduced in hypertensive individuals.
- Chronic beta-adrenergic blockade normalized spectral profiles and responsiveness, and increased baroreflex gain, suggesting a role for sympathetic activity.
Impact:
- This approach allows for better quantification of behavioral and mental factors in essential hypertension.
- Findings may aid in defining individualized treatment strategies for hypertension.
- Understanding the sympathetic nervous system's role can lead to targeted therapeutic interventions.
Related Concept Videos
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...